I-1-Deoxynojirimycin (DNJ)
Intshayelelo emfutshane:
I-1-Deoxynojirimycin, emva koku ebizwa ngokuba yi-DNJ, enamandla-glucosidase inhibitors. Emva kokufunxwa ngumzimba womntu, inokuyekisa ukusebenza kwe-invertase, i-enzyme ye-maltose, i-α-glucosidase kunye ne-α-amylase enzyme, ukunciphisa ukufunxwa kwe-carbohydrate digestion kunye ne-glucose, ukugcina inqanaba leswekile esempilweni, kunye nomsebenzi wayo we-hypoglycemic ungcono sulfonylureas, kunye neziphumo ebezingalindelekanga, ezinje ngehypoglycemia, incinci kakhulu kunezinye iziyobisi zehypoglycemic, ikwanokhuseleko olululo; Ngaphandle koko, le mveliso inefuthe elincinci kukutya okuqhelekileyo.Ukongeza, i-DNJ ikwanomsebenzi obalulekileyo we-antiretroviral, inokuthintela i-metastasis yethumba kwaye isetyenziswe njengomphathi wokudibanisa i-maltose ephezulu.
Ingcaciso: 1%, 1.5%, 2%, 3%, 5%, 10%, 20% HPLC
Inkcazo: Umdaka okanye umbala otyheli
Isinyibilikisi esisetyenzisiweyo: Amanzi, i-Ethanol
Icandelo elisetyenzisiweyo: Igqabi le-Mulberry
ICas No.: 19130-96-2
Umsebenzi:
ngempembelelo elungileyo ekugcineni iswekile esegazini esempilweni.
b. ukunceda ukuphucula ulusu lomzimba kunye nokucoca ulusu.
c. Umsebenzi weAntiviral
Ingcaciso:
IZINTO |
Ukucaciswa |
IZIPHUMO |
INDLELA |
Inkangeleko |
Umgubo omdaka |
Umgubo omdaka |
NGOKUBONAKALAYO |
Particle Ubungakanani |
I-100% idlula kwi-80 mesh |
I-100% idlula kwi-80 mesh |
USP33 |
Uvavanyo |
35.0% |
36.2% |
UV |
Ilahleko ekomiseni |
.05.0% |
3.1% |
USP33 |
Umxholo we-Ash |
.05.0% |
3.2% |
USP33 |
Amanzi aMandla (Pb) |
5pm |
0.20ppm |
I-AAS |
IArsenic |
Umzuzu |
0.12ppm |
I-AAS |
Inani elipheleleyo lePlate |
C1000cfu / g |
<100cfu / g |
USP33 |
Igwele kunye noMngundo |
100cfu / g |
<10cfu / g |
USP33 |
Salmonella |
Ukungalunganga |
Ukungalunganga |
USP33 |
E.Coli |
Ukungalunganga |
Ukungalunganga |
USP33 |
Isiphelo: Iyahambelana nemigaqo. Indawo yokugcina: Indawo epholileyo kunye eyomileyo .Gcina ukukhanya okuqinileyo kunye nobushushu. Ubomi beshelf: Min. Iinyanga ezingama-24 xa zigcinwe kakuhle. Ukupakisha: 25kg / igubu |
|||
Ukuqwalaselwa kwakhona ngu:UZeng Liu | Ivunywe ngu:U-Li Shuliang |